Skip to main content
logo
Utah Medical Products, Inc. (UTMD)
NASDAQ: UTMD · Real-Time Price · USD
72.23
+1.19 (1.68%)
At close: Nov 6, 2026, 4:00 PM EST
71.99
-0.24 (-0.33%)
After-hours: Nov 6, 2026, 7:43 PM EST

Utah Medical Products Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
11.2913.8716.6416.4714.79
Depreciation & Amortization
3.012.856.377.087.28
Stock-Based Compensation
0.370.260.230.180.17
Provision & Write-off of Bad Debts
0.37-0-0.030.030.02
Other Operating Activities
-0.66-0.36-0.69-0.4-0.09
Change in Accounts Receivable
0.34-0.842.27-0.51-1.09
Change in Inventory
1.20.59-0.67-2.35-0.49
Change in Accounts Payable
0.21-0.07-0.460.46-0.02
Change in Other Net Operating Assets
-1.43-1.48-1.380.170.59
Operating Cash Flow
14.6914.8322.2821.1521.2
Operating Cash Flow Growth
-0.94%-33.44%5.36%-0.26%5.29%

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.37-0.23-0.64-0.81-0.55
Sale of Property, Plant & Equipment
-0.03---
Sale (Purchase) of Intangibles
--0.01--0.01-
Investing Cash Flow
-0.37-0.21-0.64-0.82-0.55

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
-0.390.120.170.56
Repurchase of Common Stock
-8.36-19.97--2.5-
Common Dividends Paid
-3.98-4.26-4.28-3.16-11.47
Financing Cash Flow
-12.34-23.84-4.17-5.48-10.91

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.8-0.680.34-0.77-0.36
Net Cash Flow
2.78-9.8917.8214.089.38

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
14.3214.621.6420.3420.65
Free Cash Flow Growth
-1.92%-32.53%6.41%-1.52%7.13%
Free Cash Flow Margin
37.18%35.70%43.09%38.90%42.10%
Free Cash Flow Per Share
4.424.175.955.585.64
Levered Free Cash Flow
11.1311.7916.6618.3517.14
Unlevered Free Cash Flow
11.1311.7916.6618.3517.14

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
44.644.834.974.62
Change in Working Capital
0.32-1.8-0.23-2.23-1.01
SEC Filings: 10-K · 10-Q